Shamburg News · 8-K filed Nov 3, 2026, 8:42 AM EST

AEON Biopharma Amends Two-Year Warrants, Cutting Exercise Price to $0.20 per Share

AEON · AEON Biopharma, Inc.

  • Material agreement
  • Financing
  • Materiality: medium

On November 2, 2026, AEON Biopharma entered into a Warrant Amendment with holders of at least 67% of its Two-Year Milestone Warrants, reducing the exercise price from $0.3221 to $0.20 per share of Common Stock and from $0.3220 to $0.1999 per Pre-Funded Warrant. The Company expects approximately $6.2 million in gross proceeds from certain holders exercising at the reduced price. The amendment applies to all outstanding Two-Year Warrants, which expire on November 16, 2026, following the accelerated expiration triggered by FDA Type 2b meeting minutes announced September 30, 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 1.01, 9.01, accession 0001837607-26-000081.

Written from the filing by Shamburg Markets. Figures are as reported by the company.